Private Advisor Group’s Celgene Contingent Value Rights CELGZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-30,000
Closed -$15K – 1791
2019
Q3
$15K Buy
+30,000
New +$16.7K ﹤0.01% 1639

Private Advisor Group's CELGZ Position: Q4 2019 in Review

Private Advisor Group sold out of Celgene Contingent Value Rights (CELGZ) in Q4 2019, closing a stake of 30,000 shares — an estimated $15K sold.

Private Advisor Group first reported a position in CELGZ in Q3 2019 and held it in 1 quarter. The position peaked at $15K in Q3 2019. 0 funds tracked by Wall St. Rank hold CELGZ as of Q4 2019.

  • Private Advisor Group reported no remaining Celgene Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
  • Private Advisor Group sold 30,000 Celgene Contingent Value Rights shares in Q4 2019, an estimated $15K.
  • Private Advisor Group first reported a position in Celgene Contingent Value Rights in Q3 2019 and held it in 1 quarter.
  • Private Advisor Group's Celgene Contingent Value Rights position peaked at $15K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Celgene Contingent Value Rights as of Q4 2019.

Based on Private Advisor Group's 13F filing for Q4 2019, filed 10 Feb 2020.